Leerink Partnrs Has Bullish Forecast for ACAD Q1 Earnings
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities researchers at Leerink Partnrs increased their Q1 2025 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now anticipates that the biopharmaceutical company will earn $0.10 per share for the […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Equities researchers at Leerink Partnrs increased their Q1 2025 earnings per share (EPS) estimates for shares of ACADIA Pharmaceuticals in a note issued to investors on Sunday, April 13th. Leerink Partnrs analyst M. Goodman now anticipates that the biopharmaceutical company will earn $0.10 per share for the […]
